利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

21 条记录 (耗时 0.035 秒)

    Piperazine derivative having affinity for the histamine H3 receptor
    13.
    发明授权
    Piperazine derivative having affinity for the histamine H3 receptor 失效
    对组胺H3受体具有亲和性的哌嗪衍生物

    公开(公告)号：US08288389B2

    公开(公告)日：2012-10-16

    申请号：US12676158

    申请日：2008-09-04

    申请人： Desmond John Best ,  Sing Yeung Mak ,  Barry Sidney Orlek ,  Geracimos Rassias ,  Pamela Joan Theobald

    发明人： Desmond John Best ,  Sing Yeung Mak ,  Barry Sidney Orlek ,  Geracimos Rassias ,  Pamela Joan Theobald

    IPC分类号： A61K31/496 ,  C07D309/12

    CPC分类号： C07D309/12

    摘要： The present invention relates to 1-(1-methylethyl)-4-{[4-(tetrahydro-2H-pyran-4-yloxy)phenyl]carbonyl}piperazine or a pharmaceutically acceptable salt thereof, in particular the hydrochloride salt thereof and crystalline forms of the hydrochloride salt; to processes for the preparation of the compound or its salt; to compositions containing it; and to its use in the treatment or prophylaxis of neurological or psychiatric diseases, such as cognitive impairment, fatigue or a sleep disorder, for example in a mammal such as a human. The compound or a salt thereof has affinity for and is an antagonist and/or inverse agonist of the histamine H3 receptor.

    摘要翻译： 本发明涉及1-（1-甲基乙基）-4 - {[4-（四氢-2H-吡喃-4-基氧基）苯基]羰基}哌嗪或其药学上可接受的盐，特别是其盐酸盐和结晶 形式的盐酸盐; 制备化合物或其盐的方法; 含有它的组合物; 以及其用于治疗或预防神经或精神疾病，例如认知障碍，疲劳或睡眠障碍，例如在哺乳动物如人中的用途。 该化合物或其盐对组胺H3受体具有亲和性，并且是拮抗剂和/或反向激动剂。

    PIPERAZINE DERIVATIVE HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR
    15.
    发明申请
    PIPERAZINE DERIVATIVE HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR 审中-公开
    哌嗪衍生物具有组胺H3受体的亲和力

    公开(公告)号：US20090170869A1

    公开(公告)日：2009-07-02

    申请号：US12203946

    申请日：2008-09-04

    申请人： Desmond John BEST ,  Sing Yeung Mak ,  Barry Sidney Orlek ,  Geracimos Rassias ,  Pamela Joan Theobald

    发明人： Desmond John BEST ,  Sing Yeung Mak ,  Barry Sidney Orlek ,  Geracimos Rassias ,  Pamela Joan Theobald

    IPC分类号： A61K31/497 ,  C07D405/12

    CPC分类号： C07D309/12

    摘要： The present invention relates to 1-(1-methylethyl)-4-{[4-(tetrahydro-2H-pyran-4-yloxy)phenyl]carbonyl}piperazine or a pharmaceutically acceptable salt thereof, in particular the hydrochloride salt thereof and crystalline forms of the hydrochloride salt; to processes for the preparation of the compound or its salt; to compositions containing it; and to its use in the treatment or prophylaxis of neurological or psychiatric diseases, such as cognitive impairment, fatigue or a sleep disorder, for example in a mammal such as a human.The compound or a salt thereof has affinity for and is an antagonist and/or inverse agonist of the histamine H3 receptor.

    摘要翻译： 本发明涉及1-（1-甲基乙基）-4 - {[4-（四氢-2H-吡喃-4-基氧基）苯基]羰基}哌嗪或其药学上可接受的盐，特别是其盐酸盐和结晶 形式的盐酸盐; 制备化合物或其盐的方法; 含有它的组合物; 以及其用于治疗或预防神经或精神疾病，例如认知障碍，疲劳或睡眠障碍，例如在哺乳动物如人中的用途。 该化合物或其盐对组胺H3受体具有亲和性，并且是拮抗剂和/或反向激动剂。

    Piperazine Derivative Having Affinity for the Histamine H3 Receptor
    19.
    发明申请
    Piperazine Derivative Having Affinity for the Histamine H3 Receptor 失效
    哌嗪衍生物具有组胺H3受体的亲和力

    公开(公告)号：US20100204242A1

    公开(公告)日：2010-08-12

    申请号：US12676158

    申请日：2008-09-04

    申请人： Desmond John Best ,  Sing Yeung Mak ,  Barry Sidney Orlek ,  Geracimos Rassias ,  Pamela Joan Theobald

    发明人： Desmond John Best ,  Sing Yeung Mak ,  Barry Sidney Orlek ,  Geracimos Rassias ,  Pamela Joan Theobald

    IPC分类号： A61K31/496 ,  C07D405/12 ,  A61P25/00 ,  A61P25/28

    CPC分类号： C07D309/12

    摘要： The present invention relates to 1-(1-methylethyl)-4-{[4-(tetrahydro-2H-pyran-4-yloxy)phenyl]carbonyl}piperazine or a pharmaceutically acceptable salt thereof, in particular the hydrochloride salt thereof and crystalline forms of the hydrochloride salt; to processes for the preparation of the compound or its salt; to compositions containing it; and to its use in the treatment or prophylaxis of neurological or psychiatric diseases, such as cognitive impairment, fatigue or a sleep disorder, for example in a mammal such as a human.The compound or a salt thereof has affinity for and is an antagonist and/or inverse agonist of the histamine H3 receptor.

    摘要翻译： 本发明涉及1-（1-甲基乙基）-4 - {[4-（四氢-2H-吡喃-4-基氧基）苯基]羰基}哌嗪或其药学上可接受的盐，特别是其盐酸盐和结晶 形式的盐酸盐; 制备化合物或其盐的方法; 含有它的组合物; 以及其在治疗或预防神经或精神疾病如认知障碍，疲劳或睡眠障碍中的用途，例如在哺乳动物如人中的用途。 该化合物或其盐对组胺H3受体具有亲和性，并且是拮抗剂和/或反向激动剂。